Cornerstone Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$363K Hold
303
0.08% 41
2026
Q1
$279K Sell
303
-15
-5% -$15.2K 0.06% 39
2025
Q4
$342K Hold
318
0.08% 40
2025
Q3
$243K Hold
318
0.06% 43
2025
Q2
$248K Hold
318
0.06% 42
2025
Q1
$263K Sell
318
-15
-5% -$12.5K 0.07% 43
2024
Q4
$257K Hold
333
0.07% 45
2024
Q3
$295K Sell
333
-19
-5% -$17.1K 0.08% 42
2024
Q2
$319K Hold
352
0.1% 36
2024
Q1
$274K Hold
352
0.08% 41
2023
Q4
$205K Sell
352
-25
-7% -$14.6K 0.07% 44
2023
Q3
$202K Buy
+377
New +$194K 0.07% 42

Other funds holding LLY

Cornerstone Wealth Advisors's LLY Position: Q2 2026 in Review

Cornerstone Wealth Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 303 shares worth $363K. The position accounts for 0.08% of the portfolio, ranked #41.

Cornerstone Wealth Advisors first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 1,086 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cornerstone Wealth Advisors held 303 shares of Eli Lilly worth $363K as of Q2 2026.
  • Cornerstone Wealth Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.08% of Cornerstone Wealth Advisors's portfolio in Q2 2026, its #41 holding.
  • Cornerstone Wealth Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 1,086 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cornerstone Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.